Companies/clinical-stage biotherapeutics·no verified research yet
Generate:Biomedicines
- Series C
- Somerville, MA
- Coverage
- 3 of 5 sections
- Facts
- 5
- People
- 4
- Rounds
- 1
Identity & facts
sourced where a source is recorded- Headquarters
- Somerville, MA · as of 2026-09-24 Generate:BiomedicinesSign in to report an error: Headquarters
- Website
- generatebiomedicines.com · as of 2026-09-24 Generate:BiomedicinesSign in to report an error: Website
- Sector
- clinical-stage biotherapeutics · as of 2023-09-14 Generate:BiomedicinesSign in to report an error: Sector
- Stage
- Series C · as of 2023-09-14 Generate:BiomedicinesSign in to report an error: Stage
- Total raised
- nearly $700 million in equity financing since 2020 · as of 2023-09-14 Generate:BiomedicinesSign in to report an error: Total raised
- Geography
- Somerville, MA Sign in to report an error: Geography
- Founded
- Not recordedSign in to report an error: Founded
Intelligence — the view
not yet signedNo signed view yet. The Intelligence tab appears once the desk publishes one.
No live opportunities right now.
- Inflections
- 0
- Rounds
- 1
- Sources
- 3
What changed
No changes recorded.
| Round | Date | Raised | Post-money | Lead(s) | Source | Report an error |
|---|---|---|---|---|---|---|
| Series C | 2023-09-14 | $273M | Not recorded | Not recorded | Generate:Biomedicines | Sign in to report an error: Series C, 2023-09-14 |
Round history is public and sourced.
| Name | Role | Source | Report an error |
|---|---|---|---|
| Gevorg Grigoryan | Co-Founder & Chief Technology Officer | Generate:Biomedicines | Sign in to report an error: Gevorg Grigoryan |
| Michael Nally | Chief Executive Officer | Generate:Biomedicines | Sign in to report an error: Michael Nally |
| Jason Silvers | President & Chief Financial Officer | Generate:Biomedicines | Sign in to report an error: Jason Silvers |
| Aarif Khakoo | Chief Scientific Officer | Generate:Biomedicines | Sign in to report an error: Aarif Khakoo |
Attribution — every claim on this page traces to one of these
| Publication | What it supports | Accessed |
|---|---|---|
| About Us | Generate:Biomedicines opens in a new tab | People | accessed |
| Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics opens in a new tab | Sector, Stage, Total raised, Funding | accessed |
| Home | Generate:Biomedicines opens in a new tab | Headquarters, Website | accessed |